The Effects of Schroth Based Exercise Therapy in Adolescents with Pectus Excavatum

Not Applicable

Completed

• Conditions: Funnel Chest; Pectus Excavatum; Pectus Excavatum Deformity; Chest Deformities

• Registration Number: NCT06763406
• Lead Sponsor: Hacettepe University

Brief Summary

Research on exercise methods for pectus excavatum (PE) is limited, highlighting the need for further studies. This study investigated the effects of Schroth-based exercise therapy combined with vacuum treatment in 35 adolescents with PE, divided into a vacuum + exercise group (n=19) and a vacuum-only group (n=16). Outcomes included deformity severity, sagittal posture, thoracic cage and spinal mobility, muscle endurance, and quality of life. The combination therapy significantly improved sagittal spinal posture (craniovertebral, thoracic, thoracolumbar, lumbar angles) and deformity-specific quality of life (Nuss Questionnaire scores) compared to vacuum-only treatment.

Detailed Description

Not available

Study Timeline

• Study Start: 2023-04-15
• Primary Completion: 2024-05-01
• Study Completion: 2024-05-01
• Study First Submitted: 2024-12-04
• Status Verified: 2025-01
• Study First Submitted QC: 2025-01-06
• Last Update Submitted: 2025-01-06
• Study First Posted: 2025-01-08
• Last Update Posted: 2025-01-08

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 35

Inclusion Criteria

• having pectus excavatum
• being 10-18 years
• having Haller index more than 2.5

Exclusion Criteria

• Individuals with pectus excavatum associated with a syndrome Individuals with mixed deformity
• Individuals who have previously received any conservative treatment or surgery for chest deformity or spinal issues
• Individuals with neuromuscular, rheumatic, or chronic systemic diseases

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Primary Outcome Measure 1: Deformity Severity	12 weeks	Primary Outcome Measure 1: Deformity Severity Measurement: Anthropometric Index (cm) Details: Repeated, in cm. Time frame: The assessment will be conducted during the first week of treatment and 12 weeks after treatment
Primary Outcome Measure 2: Sagittal Spinal Posture	12 weeks	Primary Outcome Measure 2: Sagittal Spinal Posture Measurement: Lateral Photos (°) Details: In degrees Time Frame:The assessment will be conducted during the first week of treatment and 12 weeks after treatment
Primary Outcome Measure 3: Disease-Specific QoL	12 weeks	Primary Outcome Measure 3: Disease-Specific QoL Measurement: Nuss Questionnaire (1-4) Details: Higher = better Time Frame: The assessment will be conducted during the first week of treatment and 12 weeks after treatment
Primary Outcome Measure 4: General QoL	12 weeks	Primary Outcome Measure 4: General QoL Measurement: PedsQL (0-100) Details: Higher = better Time Frame: The assessment will be conducted during the first week of treatment and 12 weeks after treatment

Secondary Outcome Measures

Name	Time	Method
Secondary Outcome Measure 1: Thoracic Cage Mobility	12 weeks	Secondary Outcome Measure 1: Thoracic Cage Mobility Measurement: Chest Circumference (cm) Details: In cm Time Frame: The assessment will be conducted during the first week of treatment and 12 weeks after treatment
Secondary Outcome Measure 2: Spinal Mobility	12 weeks	Secondary Outcome Measure 2: Spinal Mobility Measurement: Sit-and-Reach (cm) Details: Highest value Time Frame: The assessment will be conducted during the first week of treatment and 12 weeks after treatment
Secondary Outcome Measure 3: Lumbar Mobility	12 weeks	Secondary Outcome Measure 3: Lumbar Mobility - Measurement: Modified Schober (cm) Details: Difference in cm Time Frame: The assessment will be conducted during the first week of treatment and 12 weeks after treatment
Secondary Outcome Measure 4: Muscle Endurance (Sit-Ups)	12 weeks	Secondary Outcome Measure 4: Muscle Endurance (Sit-Ups) Measurement: Sit-Up (reps/30s) Details: Repetitions Time Frame: The assessment will be conducted during the first week of treatment and 12 weeks after treatment
Secondary Outcome Measure 5: Muscle Endurance (Lateral Bridge)	12 weeks	Secondary Outcome Measure 5: Muscle Endurance (Lateral Bridge) Measurement: Lateral Bridge (s) Details: Duration Time Frame: The assessment will be conducted during the first week of treatment and 12 weeks after treatment

Trial Locations

Locations (1)

Hacettepe Uuniversity; 🇹🇷 Ankara, Altındağ, Turkey